1-43447886-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001365999.1(SZT2):c.9478C>T(p.Gln3160Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,613,962 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001365999.1 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SZT2 | NM_001365999.1 | c.9478C>T | p.Gln3160Ter | stop_gained | 68/72 | ENST00000634258.3 | NP_001352928.1 | |
SZT2-AS1 | NR_046744.1 | n.589G>A | non_coding_transcript_exon_variant | 2/2 | ||||
SZT2 | NM_015284.4 | c.9307C>T | p.Gln3103Ter | stop_gained | 67/71 | NP_056099.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SZT2 | ENST00000634258.3 | c.9478C>T | p.Gln3160Ter | stop_gained | 68/72 | 5 | NM_001365999.1 | ENSP00000489255 | P1 | |
SZT2-AS1 | ENST00000396885.2 | n.589G>A | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152078Hom.: 0 Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461884Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727244
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152078Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74270
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 06, 2021 | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with SZT2-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln3103*) in the SZT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SZT2 are known to be pathogenic (PMID: 23932106, 27248490, 28556953). - |
SZT2-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 16, 2024 | The SZT2 c.9307C>T variant is predicted to result in premature protein termination (p.Gln3103*). This variant was reported in the heterozygous state in an individual with epilepsy as part of a large-scale cohort sequencing study; however, a second allele was not reported, and it is unclear if this variant contributed to disease in this case (Table S2, Truty et al 2019. PubMed ID: 31440721). This variant has not been reported in a large population database, indicating it is rare. Nonsense variants in SZT2 are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at